packageRetigabine

retigabine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Retigabine (ezogabine) is an anticonvulsant that was used to treat epilepsy. It has been withdrawn, including from the European Union market.

Summary written by glm-5.3-flash from Wikidata Q2146170 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:retigabine
ATC codes:N03AX21
DrugBank:DB04953
PubChem CID:121892
ChEBI:68584
Wikidata:Q2146170
formula:C16H18FN3O2
molar mass:303.337 g/mol (PubChem CID 121892)
logP:2.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown